Ongoing virus woes in many developed markets haven’t put much of a dent in the equity market rotation that has happened since the good news about vaccines emerged in November. We expect that rotation to continue this year, accompanied by a general rally in “risky” assets.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services